COMMUNIQUÉS West-GlobeNewswire

AIT Therapeutics to Present Nitric Oxide Data at Two Upcoming Scientific Conferences
04/09/2018
Highlights at European Respiratory Society (ERS) to include updated data from company’s NO-BRO Pilot study of high-dose inhaled nitric oxide (NO) in infants hospitalized with acute bronchiolitis Additional pre-clinical [...]
Establishment Labs announces transition to a Direct Sales Force in the United Kingdom
04/09/2018
NEW YORK, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics [...]
Soleno Therapeutics Announces Issuance of New U.S. Patent for DCCR Covering Treatment of Low Lean Body Mass in Prader-Willi Syndrome
04/09/2018
REDWOOD CITY, Calif., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced [...]
Catalyst Biosciences Announces Publication of Marzeptacog Alfa (Activated) Phase 1 Data in The Journal of Thrombosis and Haemostasis
04/09/2018
SOUTH SAN FRANCISCO, Calif., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology [...]
Oryzon to present at upcoming international conferences
04/09/2018
Rodman & Renshaw 20th Annual Global Investment Conference, New York, USA 19th International Conference on Alzheimer’s Drug Discovery, Jersey City, NJ, USA BIO-SPAIN-2018, Sevilla, SPAIN European Molecular Biology [...]
Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Combination Trial for PRS-343 Plus Anti-PD-L1 Immunotherapy
04/09/2018
BOSTON, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) , a biotechnology company advancing novel biotherapeutics through its proprietary Anticalin ® technology platform for cancer, [...]
Multi-center Analysis of Outcomes Data on Use of Delcath CHEMOSAT in the Treatment of ICC to be Published in European Radiology
04/09/2018
NEW YORK, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the result of [...]
Surgery Partners, Inc. to Present at Wells Fargo Securities 2018 Healthcare Conference
04/09/2018
NASHVILLE, Tenn., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners”), a leading healthcare services company, today announced that Tom Cowhey, Chief Financial Officer will [...]
Zenith Epigenetics Announces Publication of a Case Study From its Ongoing mCRPC Clinical Study
04/09/2018
CALGARY, Alberta, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Zenith Epigenetics Ltd. (“Zenith” or the “Company”), a wholly-owned subsidiary of Zenith Capital Corp., announced today the publication of a scientific article on the [...]
Resverlogix Presents at Clinical Trials in Alzheimer’s Disease (CTAD) Asia 2018
04/09/2018
Dr. Jeffrey Cummings presents potential new therapy in dementia CALGARY, Alberta and SHANGHAI, Sept. 04, 2018 (GLOBE NEWSWIRE) -- As a follow up to its July 17, 2018 news release , Resverlogix Corp. (“Resverlogix” or [...]
Opiant Pharmaceuticals Announces Final Patient Enrolled in Phase 2 Clinical Trial Evaluating OPTN001 in Bulimia Nervosa
04/09/2018
Top-line Results Expected in First Quarter of 2019 SANTA MONICA, Calif., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing [...]
Altimmune Announces Additional Positive Data from Its Phase 2a Study of NasoVAX Intranasal Influenza Vaccine
04/09/2018
Six-month data demonstrates: A statistically superior mucosal immune response providing a first line of defense against infection; A durable serum immune response at six months compared to over 50% decline with Fluzone [...]
Tabula Rasa HealthCare Acquires Mediture and eClusive
04/09/2018
Mediture’s Electronic Health Record software solution and eClusive’s third party administrator services will expand TRHC’s presence in the PACE market and with other At-risk Providers MOORESTOWN, N.J., Sept. 04, 2018 ( [...]
BrainStorm Appoints Arturo Araya as Chief Commercial Officer
04/09/2018
Mr. Araya was Global Head of Commercial of Novartis Cell & Gene Therapies Unit Appointment strengthens leadership team with nearly 20 years of global pharmaceutical marketing and commercialization experience NEW [...]
Alavida continues rapid expansion across Canada: Now in Manitoba
04/09/2018
WINNIPEG, Manitoba, Sept. 04, 2018 (GLOBE NEWSWIRE) -- On the heels of their most recent financial raise, Alavida Health - a science-based innovative outpatient treatment for Heavy Drinking, expands its operations to [...]
Vistin Pharma ASA : Q2 2018 presentation
04/09/2018
Oslo, Norway, 4 September 2018 Reference is made to the release of the second quarter 2018 results on 30 August 2018 for Vistin Pharma ASA. Please find attached the investor presentation held today at Carnegie in [...]
Sanofi: Disclosure of trading in own shares
04/09/2018
Attachment Reporting EN.pdf
Sanofi : Déclaration des transactions sur actions propres
04/09/2018
Pièce jointe Reporting FR.pdf
Biogen Enrolls First Patient in Global Phase 3 Study of BIIB093 (IV Glibenclamide) for Large Hemispheric Infarction
04/09/2018
CHARM study will evaluate IV glibenclamide for the prevention and treatment of severe cerebral edema in LHI, one of the most severe types of ischemic stroke with limited treatment options Prior studies demonstrated IV [...]

Pages